BRUE, or Brief Resolved Unexplained Events, is a medical condition that has been increasingly recognized in the medical community. It is a relatively new diagnosis, and it is still not fully understood. Because of its mysterious nature, it can be difficult for doctors to diagnose and treat. In this article, we will explore the mysterious case of BRUE, what is known about the condition, and how doctors can best diagnose and treat it. BRUE is a relatively new diagnosis, first described in 2016. It is a condition characterized by an event in which an infant stops breathing for at least 20 seconds and then resumes breathing on their own. It is often referred to as an “alarm event” because it is often preceded by an alarm-like sound or sensation. BRUE can occur at any age, but it is most common in infants. It is estimated that BRUE affects up to 1 in 10,000 infants in the United States each year. BRUE is a diagnosis of exclusion, meaning that other possible causes of the event must be ruled out before a diagnosis of BRUE can be made. Common causes of these events include sleep apnea, seizures, gastroesophageal reflux, and airway obstruction. In order for a diagnosis of BRUE to be made, all other possible causes must be ruled out.
The diagnosis of BRUE is based on the history of the event as reported by the parents or caretakers. It is important for doctors to ask questions about the event and to look for any signs or symptoms that may indicate a different cause. Doctors should also perform a physical examination of the infant to look for any signs of underlying illness or injury. In addition to the history and physical examination, doctors may also order tests to help rule out other possible causes. These tests may include an electroencephalogram (EEG) to look for seizure activity, a chest X-ray to look for any abnormalities in the lungs, or a laryngoscopy to look for any blockage in the airway.
Once a diagnosis of BRUE has been made, the goal of treatment is to prevent future events. The most common treatment for BRUE is lifestyle modifications such as avoiding triggers that may cause the events, such as loud noises or sudden movements. Itis also important for parents to ensure that the infant is getting enough rest and is not being over-stimulated. In some cases, medications may also be prescribed to help prevent future events. Commonly used medications include anticonvulsants and sedatives. It is important to note that medications should only be used as a last resort and should be used with caution.
BRUE is a mysterious condition that can be difficult to diagnose and treat. It is important for doctors to take a thorough history and perform a physical examination of the infant in order to rule out other possible causes. Once a diagnosis of BRUE has been made, lifestyle modifications and, in some cases, medications can be used to help prevent future events. With the proper diagnosis and treatment, the prognosis for infants with BRUE is generally good.
1.
Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer
2.
Pediatric high-grade gliomas: Research reveals effective targeting with avapritinib
3.
In prostate cancer survivorship, sleep disturbances are underappreciated.
4.
Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer
5.
a cutting-edge cancer diagnostic tool.
1.
Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms
2.
Community Survivorship Networks for Long-Term Cancer Wellness
3.
Neuroendocrine Tumors: Case Study on Diagnosis, Treatment Strategies & Patient Management
4.
Targeted Therapies for Breast Cancer: What’s New?
5.
Integrated Insights in Hematology and Quality Improvement
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Hands-on Workshop: Hematology
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation